Protein fibrilization and Parkinson's disease.

被引:0
|
作者
Lansbury, PT [1 ]
Ding, T [1 ]
Lashuel, H [1 ]
Rochet, DC [1 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Neurol, Cambridge, MA 02139 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
147-PHYS
引用
收藏
页码:C41 / C42
页数:2
相关论文
共 50 条
  • [31] Amantadine in the therapy of Parkinson's disease.
    Baumhackl, U
    Klingler, D
    NEUROPSYCHIATRIE, 1995, 9 : S23 - S24
  • [32] The personality associated with Parkinson's disease.
    Menza M.
    Current Psychiatry Reports, 2000, 2 (5) : 421 - 426
  • [33] Genetic aspect of Parkinson's disease.
    Brassat, D
    Durr, A
    Agid, Y
    Brice, A
    REVUE DE MEDECINE INTERNE, 1999, 20 (08): : 709 - 714
  • [34] Translational research in Alzheimer's disease and Parkinson's disease.
    Schmechel, Don
    NEUROTOXICOLOGY, 2006, 27 (06) : 1157 - 1157
  • [35] Treatment complications in Parkinson's disease. Is Parkinson's disease dementia worth treating?
    de Fabregues Boixar-Nebot, Oriol
    REVISTA DE NEUROLOGIA, 2010, 50 : S48 - S50
  • [36] RNA binding protein mediated regulation of striatal transcriptome in Parkinson's disease.
    Irmady, K.
    Hale, C.
    Scheckel, C.
    Fak, J.
    Darnell, R.
    MOVEMENT DISORDERS, 2019, 34 : S725 - S725
  • [37] Patient's perceptions of living with Parkinson's disease.
    Whetten-Goldstein, K
    Cutson, TM
    Zhu, CW
    Schenkman, M
    GERONTOLOGIST, 2001, 41 : 281 - 282
  • [38] Parathyroids in four cases of Parkinson's disease.
    Roussy, G
    Clunet, J
    COMPTES RENDUS DES SEANCES DE LA SOCIETE DE BIOLOGIE ET DE SES FILIALES, 1910, 68 : 320 - 323
  • [39] Depression in Parkinson's disease. The role of pharmacotherapy
    Wierzbinski, Piotr
    Sobow, Tomasz
    AKTUALNOSCI NEUROLOGICZNE, 2018, 18 (01): : 14 - 20
  • [40] Rivastigmine for dementia associated with Parkinson's disease.
    Morgan J.
    Sethi K.D.
    Current Neurology and Neuroscience Reports, 2005, 5 (4) : 263 - 265